Fund Holdings — Medicxi Ventures Management (Jersey) Ltd

Total Portfolio Value
$296.23M
Total Bought
$0
Total Sold
$53.52M
Net Transaction
-$53.52M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q3 2023
▲▼
Q4 2023
▲▼
Change
▲▼
Q3 2023
▲▼
Q4 2023
▲▼
Weight (%)
▲▼
Change
▲▼
CENTESSA PHARMACEUTICALS PLC19,963,15719,963,1570129,162158,90753.64%+29,745
MERUS N V1,600,0001,600,000037,72844,00014.85%+6,272
NEWAMSTERDAM PHARMA COMPANY
ORDINARY SHARES
2,869,5652,869,565026,54332,05310.82%+5,510
AURA BIOSCIENCES INC(AURA)3,039,8923,039,892027,26826,9339.09%-334
PHATHOM PHARMACEUTICALS INC(PHAT)3,760,8693,760,869039,00034,33711.59%-4,663
VAXCYTE INC(PCVX)1,049,8930-1,049,89353,5240—-53,524
Page 1 of 1
Medicxi Ventures Management (Jersey) Ltd — 13F Holdings — Q4 2023 | TickerTrail